Fundraising FoxNeurOp
Atlanta, US · 1 known investors
Find your way into NeurOp
Sign up to see every warm intro you have to NeurOp
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NeurOp team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NeurOp develops novel pharmaceutical compounds targeting NMDA receptors for the treatment of pain, stroke, subarachnoid hemorrhage, and severe depression. The company's lead candidate, NP10679, is in early-stage clinical development.
Founders & leadership
RD
Raymond DingledineCo-founder
JO
James O. McNamaraExecutive Chairman & Co-founder
ST
Stephen TraynelisCo-founder
RB
Robert BonczekNamed on SEC filing
DL
Dennis LiottaNamed on SEC filing
GK
George KoszalkaPresident/CEO
Investors · 1
Reported raises · per SEC filings
Form D private placements$155K disclosed across 1 round · 2014
▶$155KraisedFeb 2014 · 5 investors · BiotechnologyRule 506(b)
▶$155KraisedFeb 2014 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert BonczekDirector
- James McNamaraDirector
- Dennis LiottaDirector
- George KoszalkaExecutive Officer, Director
- Raymond DingledineDirector
- Amount sold
- $155K
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does NeurOp do?
- NeurOp develops novel pharmaceutical compounds targeting NMDA receptors for the treatment of pain, stroke, subarachnoid hemorrhage, and severe depression. The company's lead candidate, NP10679, is in early-stage clinical development.
- Who founded NeurOp?
- NeurOp was founded by Raymond Dingledine, James O. McNamara, Stephen Traynelis.
- Who are NeurOp's investors?
- NeurOp's investors include Arieal Southeast Angel Partners.
- How much funding has NeurOp raised?
- NeurOp has disclosed $155K raised across 1 round.
- Where is NeurOp headquartered?
- NeurOp is headquartered in Atlanta, US.